Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 68071-3659

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68071-3659). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3659 9)

Atorvastatin Calcium 20 mg film-coated tablets label from NuCare Pharmaceuticals, Inc. The label states a package count of 90 tablets. It includes usage instructions, manufacturer and packaging details, lot and expiration placeholders, barcodes, and warnings to keep out of reach of children and store at 68-77°F. The label is marked Rx Only.*

FDA Label Image

Atorvastatinfigure1. (Atorvastatinfigure1)

Chemical structure of atorvastatin calcium, showing the molecular arrangement including phenyl groups, fluorine, hydroxyl groups, and calcium complexed with water molecules.*

FDA Label Image

Atorvastatinfigure2. (Atorvastatinfigure2)

A line graph showing cumulative incidence over a period of 3.5 years comparing Atorvastatin to a placebo. The x-axis represents years, and the y-axis shows cumulative incidence percentage. The graph depicts Atorvastatin with a solid line and placebo with a dashed line, indicating lower cumulative incidence for Atorvastatin compared to placebo.*

FDA Label Image

Atorvastatinfigure3. (Atorvastatinfigure3)

A line graph showing cumulative hazard (%) over time in years for Atorvastatin and placebo groups. The x-axis represents time to first primary endpoint through four years of follow-up, and the y-axis shows cumulative hazard percentage. The Atorvastatin group shows a lower cumulative hazard compared to placebo, with a hazard ratio of 0.63 (0.48-0.83) and p-value of 0.001.*

FDA Label Image

Atorvastatinfigure4. (Atorvastatinfigure4)

A line graph comparing the subject experiencing event percentage over time to the first major cardiovascular endpoint (in years) for Atorvastatin 10 mg and 80 mg doses. The graph includes a hazard ratio (HR 0.78) with confidence intervals and a p-value indicating statistical significance.*

FDA Label Image

Atorvastatinfigure9 (Atorvastatinfigure9)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.